Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer
NCT ID: NCT02464982
Last Updated: 2016-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
107 participants
OBSERVATIONAL
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study purpose is to measure the patient's esthetic satisfaction degree on 1year areola tattoo realized following standard care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)
NCT05842148
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant
NCT05213962
Body-image Satisfaction Following Permanent Black or Invisible UV Ink Tattoos
NCT03131011
Satisfaction and QUality of Life After Breast REconstruction
NCT04329819
Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy
NCT03523078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Tattooed patient's satisfaction degree with qualitative questionnaire using four level satisfaction scale (very satisfied, satisfied, dissatisfied, very dissatisfied)
* Evaluate from patient and jury, the tall, form, color and areola position defects
* Evaluate professional jury's satisfaction degree regarding this areola tattoo technology, with the same patient criteria
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with 1 year non-invasive technology areola tattoo
Women with 1 year non-invasive technology areola tattoo realized in standard care as part of 1 breast mammary reconstruction following an operated breast cancer
Tattoo
tattoo device with EC standards, and sterile single-use only needle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tattoo
tattoo device with EC standards, and sterile single-use only needle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* surgical reconstruction
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie DUGUET
Role: PRINCIPAL_INVESTIGATOR
esthetic, reconstruction and maxillo-facial surgery department, University Hospital, Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
esthetic, reconstruction and maxillo-facial surgery department, University Hospital
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRIP 2011 / 1 AMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.